T
This biotechnology company specializes in the field of Targeted Protein Degradation (TPD). They develop novel therapeutic modalities aimed at selectively eliminating disease-causing proteins within cells. Their focus is on advancing small molecule approaches to modulate protein homeostasis for therapeutic benefit.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This biotechnology company specializes in the field of Targeted Protein Degradation (TPD). They develop novel therapeutic modalities aimed at selectively eliminating disease-causing proteins within cells. Their focus is on advancing small molecule approaches to modulate protein homeostasis for therapeutic benefit.